Table:
begin	end	state
1	221	cytoplasmic
222	241	transmembrane
242	261	non-cytoplasmic
262	283	transmembrane
284	322	cytoplasmic
323	345	transmembrane
346	351	non-cytoplasmic
352	371	transmembrane
372	390	cytoplasmic
391	412	transmembrane
413	431	non-cytoplasmic
432	455	transmembrane
456	499	cytoplasmic
500	520	transmembrane
521	525	non-cytoplasmic
526	545	transmembrane
546	548	cytoplasmic

Input:
>WP_055067247.1 NCBI__GCF_001406815.1:WP_055067247.1
MANSKILTAEQEKTLRQPIEEYVGKIQKEIDELRKDGTAKVIMYQSRIENVKRDKTLSKG
EKDSEIASCQKELEQAKAVEAQNKDQIAKLIGKAENYLKNNFDKYYNAVKASCIAEKEQA
LQEHQQKLAKIEKEHKETLAKTSAQAEVKEENYVYKNRVSNEKIELEKEYQRIKDRKHDA
YSYKYHLIDLLRLSKFTFAENQAQKWENYKYTFNRRTFLLQNGLYIAIILIFVALCIITP
IKKGTPLLTYNNILNILQQASPRMFLALGVAGLILLTGTDLSVGRMVGMGMTTATIIMHQ
GVNTGGVFGHIFDFTKVPTPARVILALVACIVLCTFFTSIAGFFTAKFKMHPFISTMANM
LVIFGLVTYATKGVSFGAIEPTIPNMVIPKVNGFPTIILWAVAAIVIVWFIWNKTTFGKN
LYAVGGNPEAAAVSGISVFAVTLGAFIMAGILYGFGSWLECTRMVGSGSAAYGQGWDMDA
IAACVVGGVSFTGGIGKISGVVTGVCIFTALTYSLTILGIDTNLQFVFSGIIILVAVTLD
CLKYVQKK

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server